24/7 Customer Support

Neurostimulation Device Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Global Neurostimulation Device Market- (By Type – Implantable Device and External Device; By Application - Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, and Others; By End User - Hospitals/Clinics, Cognitive Care Centers, Research Institutes, and Others; and By Region) - Industry Dynamics, Market Size and Opportunity Forecast, 2030

  • Published On: 11-May-2022  |  Format: pdfpowerpointexcel  |  Report ID: AA0522231
    Delivery: 2 to 4 Hours
INFOGRAPHIC:
Neurostimulation Device Market

View Full Infographic

REPORT SCOPE

Market Size Value in 2021US$ 7,622.7 Mn                                 
Expected Revenue in 2030US$ 17,367 Mn
Historic Data2017-2020
Base Year2021
Forecast Period2022-2030
UnitValue (USD Mn)
CAGR9.7% (2022-2030)
Segments coveredBy Device Type, By Application, By End-User, By Region
Key Companies                                                                                                               Medtronic plc, Cochlear Ltd., Boston Scientific Corporation, and Abbott Laboratories, Inc. among others                                                                                                                                                                                                                                                             
Customization ScopeGet your customized report as per your preference. Ask for customization

FREQUENTLY ASKED QUESTIONS

The Global Neurostimulation Device Market was valued at US$ 7,622.7 Mn in 2021.

Neurostimulation is changing the face of neurological rehabilitation as it has a wide variety of uses including pain relief, treatment for psychiatric diseases, and more recently treat movement disorders such as multiple sclerosis and spinal cord injury.

Neurological disorders include epilepsy, Alzheimer’s disease, other dementias, cerebrovascular diseases including stroke, Parkinson's disease, neuro infections, and brain tumors, among others.

The market is majorly driven by factors such as the increasing incidence of neurological disorders and rising investment in neurological R&D.

The high cost of neurostimulation procedures and equipment is restraining the market growth.

The Global Neurostimulation Device Market is segmented based on device type, application, end-users, and region.

Global Neurostimulation Device Market is projected to expand at a CAGR of 9.7% over the forecast period.

Implantable devices hold the highest market share in 2021.

Pain management segment dominates the Global Neurostimulation Device Market in 2021.

Hospitals/clinics are the highest end-users in the market in 2021.

North America dominates the Global Neurostimulation Device Market in 2021.

Asia Pacific is recording the highest growth rate over the forecast period.

The key players in the Global Neurostimulation Device Market are Medtronic plc, Cochlear Ltd., Boston Scientific Corporation and Abbott Laboratories, Inc. among others.

{